and eosin stained tissue sections of 12 breast cancers, apoptotic cells, recognised by strict morphological criteria, were counted in consecutive fields of vision at x1000 magnification in a marked area in the most poorly differentiated region of tumour. These counts were regarded as the gold standard. Subsequently, in a systematic sampling experiment, the number of fields that had to be counted to derive an acceptable coefficient of variation (CV) was determined. To compare counts at different magnifications, all fields of vision were also counted at x630 and x400. The intra-and inter-observer reproducibility was tested by repeated measurements at these magnifications in 10 systematically selected fields of vision. Results-Apoptosis seemed to be a rare event, affecting, on average, about 1% of tumour cells. Noticeable clustering of apoptotic cells was observed. The systematic sampling experiment showed that at x1000 magnification, the CV was improved by counting up to 20 fields. When comparing x400 and x630 magnifications with the x1000 magnification, the correlation coefficients were 0.88 and 0.87, respectively. However, the lower magnifications yielded lower counts. With regard to reproducibility, the intra-observer correlation coefficient was 0.91 at x630 and 0.76 at x400. The inter-observer correlation coefficient was 0.77 at x630 and 0.68 at x400. Conclusions-Apoptotic cells can be counted readily in haematoxylin and eosin stained tissue sections. However, a systematic sampling protocol must be followed and cells should be counted at a relatively high magnification to obtain acceptable reproducibility. The suggested protocol will permit further correlative and prognostic studies and the monitoring of the effects of treatment. Breast cancer is the most common cancer affecting women in the western world, the incidence of which is still increasing, especially among younger women. Despite radical surgery, many patients die of distant metastases. Therefore, adjuvant therapy is indicated in high risk patients. These patients are usually identified by lymph node positivity. However, the accuracy of lymph node status in predicting prognosis is only about 65%, so additional prognostic factors are desirable. Proliferation variables assessed in the primary tumour are prognostically very important in breast cancer,1''3 probably because the proliferative capacity of established distant metastases can be predicted from the primary tumour. Tumour growth, however, is a balance between proliferation on the one hand and cell death by necrosis and apoptosis on the other. It is often claimed that apoptosis is the most important component of continuous cell loss in tumours, although quantitative data are as yet rare. [14] [15] [16] Apoptosis is an important and interesting mechanism for cell death as it affects individual cells and is, more or less, an endogenous process. Expression of genes inhibiting (bcl-2) or promoting (p53, c-myc) apoptosis may be altered clonally in tumour cells by-for example, mutations or deletions, being the same in the primary tumour and its metastases. One study'7 has, in this context, showed apoptotic counts to be prognostically important. Reliable methods for assessing the number of apoptotic cells are of the utmost importance for the study of prognosis and cell biology.
Several methods have been applied to assess apoptosis. Flow cytometry has been used" [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] and markers for apoptotic cells have been described which may facilitate counting.23 Apoptotic cells, however, can be easily recognised in haematoxylin and eosin stained tissue sections. '7 23 However, methodological studies evaluating sources of error in the enumeration of apoptotic cells are rare. The aim of this study, therefore, was to develop a reproducible sampling protocol for counting apoptotic cells in haematoxylin and eosin stained sections. Such a protocol could be used to monitor the effects of treatment induced apoptosis.
Methods
Haematoxylin and eosin stained sections, 4 ,um thick, from 12 randomly selected cases of preoperatively untreated invasive ductal breast cancer were studied. All tumour material had been cut into slices 0.5 cm thick and fixed in neutral buffered formalin for [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] hours. In these sections, the most poorly differentiated invasive area at the periphery of the tumour was marked for counting of apoptotic cells (fig 1) . In the first experiment, apoptotic cells were counted twice by the same observer (HvdS) in all fields of vision (up to a maximum of 100) containing invasive tumour at a magnification of xlOOO (objective xlOO, field diameter 180 ptm). The correlation coefficient between the first and second assessments was 0.99. These counts were then used as a gold standard. For each case, a map was composed showing 100 fields with the apoptotic count depicted per field, and referred to as the "apoptotic map" (fig 2) .
Using these data, a sampling simulation experiment was carried out based on systematic sampling. 24 Figure 3 shows the relation between sample size and CV from the systematic sampling experiment. Up to a sample of 20 fields, the CV gradually decreased, but assessing more fields of vision did not improve these results greatly. Table 3 shows the results of the intra-and inter-observer reproducibility experiments. For these experiments, case 6 (which had a very high apoptotic count) was excluded from the analysis as this outlier biased the results positively. The intra-observer correlation coefficient was 0.91 at x630 and 0.76 at x400. The inter-observer correlation coefficients were 0.77 and 0.68 at x630 and x400, respectively. Figures 4 and 5 show the results of the intraand inter-observer reproducibility tests atx630.
Discussion
The aim of the present study was to arrive at a reproducible sampling technique for counting 40 Inter-observer reproducibility of apoptotic counts at x630 (systematic ra; M216 group.bmj.com on June 18, 2017 -Published by http://mp.bmj.com/ Downloaded from studying apoptosis in human breast cancer and possibly also for other human tumours. In tissue sections, sampling is difficult not only because of the rarity of apoptosis but also because of the clustering phenomenon. Systematic sampling, which has been found to be useful for other applications,24 is therefore mandatory.
The xlOOO magnification should be regarded as the gold standard, as small apoptotic figures present in the later phases of apoptosis can be recognised. However, because of the small field of vision, extensive sampling is required, and the use of an oil immersion lens is impractical. We therefore also tested lower magnifications. At x630, some apoptotic cells may be missed, as the counts at this magnification were systematically lower than at xlOOO. However, the intra-and inter-observer reproducibility was still good at x630, and sampling at this magnification takes less time and does not require the use of an oil immersion lens. At x400, the counts were, on average, even lower and reproducibility was noticeably worse. Therefore, when considering reproducibility, efficiency and practicality, a protocol based on random sampling at x630 seems optimal. One can accept the small systematic error resulting from the omission of some small apoptotic figures. This protocol can be used to follow large groups of patients with invasive breast cancer to evaluate the prognostic value of apoptotic counts compared with proliferation variables and to study correlations between apoptotic counts and other prognostic variables.
These results expand on those of Wijsman et al,2" who found good reproducibility when counting apoptotic cells in whole tissue sections at x630. No reproducibility data were included in a previous clinical study. ' 7 Compared with flow cytometry, counting in sections has the advantage of being able to select a specific morphological area for counting (thus avoiding benign cells) and that it is also suitable for detecting a few apoptotic figures within numerous tumour cells.
In conclusion, apoptotic cells can be counted readily in haematoxylin and eosin stained tissue sections. However, a systematic sampling protocol must be followed and cells should be counted at a relatively high magnification to obtain acceptable reproducibility. The suggested protocol will permit further correlative and prognostic studies and the monitoring of the effects of treatment.
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